4.8 Article

2'-Deoxyriboguanylurea, the primary breakdown product of 5-aza-2'-deoxyribocytidine, is a mutagen, an epimutagen, an inhibitor of DNA methyltransferases and an inducer of 5-azacytidine-type fragile sites

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Use of hypomethylating agents and associated care in patients with myelodysplastic syndromes: a claims database study

Hind T. Hatoum et al.

CURRENT MEDICAL RESEARCH AND OPINION (2011)

Review Oncology

Hypomethylating agents for urologic cancers

Ajjai S. Alva et al.

FUTURE ONCOLOGY (2011)

Article Oncology

Global Reactivation of Epigenetically Silenced Genes in Prostate Cancer

Ilsiya Ibragimova et al.

CANCER PREVENTION RESEARCH (2010)

Article Biochemistry & Molecular Biology

5-azacytidine treatment reorganizes genomic histone modification patterns

Vitalina M. Komashko et al.

Epigenetics (2010)

Article Biochemistry & Molecular Biology

Recovery of bisulfite-converted genomic sequences in the methylation-sensitive QPCR

Kristofer Munson et al.

NUCLEIC ACIDS RESEARCH (2007)

Review Genetics & Heredity

Immunodeficiency, centromeric region instability, facial anomalies syndrome (ICF)

Melanie Ehrlich et al.

ORPHANET JOURNAL OF RARE DISEASES (2006)

Article Biochemistry & Molecular Biology

Transgene-induced CCWGG methylation does not alter CG methylation patterning in human kidney cells

T Shevchuk et al.

NUCLEIC ACIDS RESEARCH (2005)

Article Biochemistry & Molecular Biology

Maintenance DNA methylation of nucleosome core particles

M Okuwaki et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2004)

Article Oncology

Preferential response of cancer cells to zebularine

JC Cheng et al.

CANCER CELL (2004)

Article Biochemistry & Molecular Biology

Zebularine: A novel DNA methylation inhibitor that forms a covalent complex with DNA methyltransferases

L Zhou et al.

JOURNAL OF MOLECULAR BIOLOGY (2002)

Article Biochemistry & Molecular Biology

Synthesis of oligonucleotide inhibitors of DNA (cytosine-C5) methyltransferase containing 5-azacytosine residues at specific sites

RG García et al.

ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT (2001)